Condition: NPC Patients · Nasopharyngeal Cancinoma (NPC) · Sponsor: Cheng-En Hsieh
To prospectively investigate and integrate radiomic and immunologic signatures in patients with nasopharyngeal carcinoma (NPC) treated with either proton or photon radiotherapy, with the aim of identifying biomarkers associated with treatment response, toxicity, and long-term outcomes.
This description comes directly from the study's public registry record.
Rodney Cheng-En Hsieh, MD, PhD · +886-3-328-1200 · rodney445@gmail.com
Always discuss trial participation with your own doctor first.
| Chang Gung Memorial Hospital at Linkou | Taoyuan City, Taiwan, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07232680